来源:[1] Omeros:诺和诺德交易凸显MASP-3替代途径靶向 (https://seekingalpha.com/article/4830870-omer ...)[2] Omeros (OMER) 股票在与诺和诺德达成21亿美元交易后飙升 - GuruFocus (https://www.gurufocus.com/news/2290000/omeros ...)[3] 与诺和诺德达成协议使该股票一夜之间上涨181%。现在是买入时机吗? (https://www.fool.com/investing/2025/10/16/a-d ...)